Valuation: FONAR Corporation

Market Cap 125M 110M 102M 93.74M 176M 12.04B 179M 1.21B 474M 5.92B 470M 459M 20.47B P/E 2024
10.3x
P/E 2025 11.9x
Enterprise Value 108M 94.45M 87.84M 80.6M 151M 10.36B 154M 1.04B 407M 5.09B 404M 395M 17.6B EV / Sales 2024
0.9x
EV / Sales 2025 0.77x
Free-Float
76.43%
Yield 2024 *
-
Yield 2025 -
1 day-0.10%
3 months+1.38%
6 months+2.58%
Current year+2.86%
Current year 18.3
Extreme 18.3
19.16
1 year 13.9
Extreme 13.9
19.16
3 years 12
Extreme 12
24.05
5 years 12
Extreme 12
24.05
10 years 11
Extreme 11
33.9
Manager TitleAgeSince
Chief Executive Officer 61 2016-02-10
Director of Finance/CFO 71 2022-08-31
Investor Relations Contact - 1978-05-31
Director TitleAgeSince
Chairman 61 2022-09-06
Date Insider Type Main position Quantity % Market Cap.
6/3/26 Other

Director

0 0%
6/3/26 Other

Chief Executive Officer

0 0%
6/3/26 Other

Chief Financial Officer

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-0.10%-.--%+18.79%+12.16% 125M
-0.71%+6.72%+18.80%-0.46% 211B
-0.52%-6.05%-6.80%-25.11% 135B
+1.65%-2.29%-31.94%+1.99% 119B
+1.54%+0.50%-58.31%-15.57% 65.77B
-1.42%-3.62%+3.29%-9.87% 47.58B
+3.03%-0.17%-26.91%-33.60% 44.44B
-0.84%+5.41%+15.30%+8.84% 39.14B
-2.02%+1.54%+23.68%+30.76% 36.79B
-1.41%+3.99%+77.58%+2.50% 29.37B
Average -0.08%+0.52%+3.35%-2.83% 72.82B
Weighted average by Cap. -0.00%+0.37%-2.58%-6.42%

Financials

2024 2025
Net sales 103M 90.36M 84.04M 77.11M 145M 9.91B 147M 998M 390M 4.87B 386M 378M 16.84B 104M 91.65M 85.23M 78.21M 147M 10.05B 149M 1.01B 395M 4.94B 392M 383M 17.08B
Net income 10.57M 9.28M 8.63M 7.92M 14.88M 1.02B 15.11M 102M 40.04M 500M 39.67M 38.82M 1.73B 8.33M 7.32M 6.81M 6.25M 11.74M 803M 11.92M 80.84M 31.58M 395M 31.29M 30.61M 1.36B
Net Debt -14.8M -13M -12.09M -11.09M -20.84M -1.43B -21.17M -144M -56.09M -701M -55.56M -54.37M -2.42B -17.54M -15.4M -14.32M -13.14M -24.7M -1.69B -25.08M -170M -66.45M -830M -65.83M -64.41M -2.87B
Logo FONAR Corporation
FONAR Corporation is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (MRI) for the detection and diagnosis of human diseases. The Company conducts its business in two segments: medical equipment and physician management and diagnostic services. Its medical equipment segment is conducted directly through the Company. Its physician management and diagnostic services segment is conducted through its subsidiary, Health Management Corporation of America (HMCA). Its signature product is the FONAR UPRIGHT Multi-Position MRI (STAND-UP MRI). HMCA provides management services, administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, hiring, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging. HMCA owns and operates six diagnostic imaging facilities in Florida.
Employees
535
  1. Stock Market
  2. Stocks
  3. FONR Stock